5-Methylsalicylic acid → N-{3,5-Bis[(1,1-dimethyl)ethyl]phenyl}-2-hydroxy-5-methylbenzamide

HRID 421152

Reaktionsgleichung

Reaktionsgleichung von HRID 421152
[CH3:1][C:2]1[CH:10]=[C:6]([C:7]([OH:9])=O)[C:5]([OH:11])=[CH:4][CH:3]=1.[CH3:12][C:13]([C:16]1[CH:17]=[C:18]([CH:20]=[C:21]([C:23]([CH3:26])([CH3:25])[CH3:24])[CH:22]=1)[NH2:19])([CH3:15])[CH3:14]>>[CH3:15][C:13]([C:16]1[CH:17]=[C:18]([NH:19][C:7](=[O:9])[C:6]2[CH:10]=[C:2]([CH3:1])[CH:3]=[CH:4][C:5]=2[OH:11])[CH:20]=[C:21]([C:23]([CH3:26])([CH3:25])[CH3:24])[CH:22]=1)([CH3:12])[CH3:14]

Komponenten

3

Edukt 2

HCID 69735-Methylsalicylic acidHCID 754193,5-Di-tert-butylaniline

Produkt 1

HCID 66657146N-{3,5-Bis[(1,1-dimethyl)ethyl]phenyl}-2-hydroxy-5-methylbenzamideAusbeute 16,3 %

Versuchsvorschrift

Using 5-methylsalicylic acid and 3,5-bis[(1,1-dimethyl)ethyl]aniline as the raw materials, the same operation as the example 16 gave the title compound.

Quellen und Nachweise

ORD-Eintrag
ord-a04cbac6fec24271b459fceef0e6a191
Quelldatensatz
uspto-grants-2012_01
Patentnummer
US08097759B2

Verknüpfte Notizen

Wird geladen…